XML 91 R9.htm IDEA: XBRL DOCUMENT
v3.19.3

OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS | 9 Months Ended
--- | ---
Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS | OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Composition of Certain Financial Statement Captions Components of selected captions in the consolidated condensed balance sheets consisted of the following (in millions):
| September 30, 2019 |  | December 31, 2018
Inventories |  |  |
Raw materials | $ | 125.8 |  |  | $ | 111.5 |
Work in process | 148.6 |  |  | 144.8 |
Finished products | 336.7 |  |  | 350.7 |
| $ | 611.1 |  |  | $ | 607.0 |
At September 30, 2019 and December 31, 2018, $122.5 million and $106.5 million, respectively, of the Company's finished products inventories were held on consignment. During the three months ended June 30, 2019, the Company recorded a $46.2 million charge to "Cost of Sales," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its CENTERA program. During the three months ended September 30, 2019, the Company recorded an additional $26.9 million charge to "Cost of Sales" resulting from refinements to its portfolio strategy, which consists mainly of an additional write off of inventory. This amount includes an out-of-period adjustment of $10.3 million. The Company determined that the out-of-period adjustment is not material to the three or nine months ended September 30, 2019 or to any prior periods.
| September 30, 2019 |  | December 31, 2018
Accounts payable and accrued liabilities |  |  |  |  |
Accounts payable | $ | 135.9 |  |  | $ | 134.0 |
Employee compensation and withholdings | 262.2 |  |  | 226.1 |
Taxes payable (Note 14) | 18.9 |  |  | 31.3 |
Property, payroll, and other taxes | 43.2 |  |  | 39.5 |
Research and development accruals | 61.2 |  |  | 48.9 |
Accrued rebates | 78.0 |  |  | 80.0 |
Fair value of derivatives | 4.5 |  |  | 4.4 |
Accrued marketing expenses | 14.7 |  |  | 22.3 |
Litigation and insurance reserves | 18.9 |  |  | 196.7 |
Accrued relocation costs | 16.7 |  |  | 11.3 |
Accrued professional services | 12.2 |  |  | 11.0 |
Accrued realignment reserves | 16.4 |  |  | 6.8 |
Other accrued liabilities | 68.9 |  |  | 64.3 |
| $ | 751.7 |  |  | $ | 876.6 |
Supplemental Cash Flow Information (in millions)
| Nine Months Ended September 30,
| 2019 |  | 2018
Cash paid during the year for: |  |  |
Income taxes | $ | 53.9 |  |  | $ | 227.3 |
Amounts included in the measurement of lease liabilities: |  |  |
Operating cash flows from operating leases | $ | 19.5 |  |  | $ | — |
Non-cash investing and financing transactions: |  |  |  |  |
Fair value of shares issued in payment for contingent consideration liabilities | $ | — |  |  | $ | 34.3 |
Right-of-use assets obtained in exchange for new lease liabilities | $ | 33.2 |  |  | $ | — |
Capital expenditures accruals | $ | 26.4 |  |  | $ | 23.7 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration